MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and… Oct 27, 2021
MYND Life Sciences Working On Truly Novel Research For Depressive And Neurological Diseases Jun 24, 2021